Search Results - "Lichtman, Stuart M"

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology by Mohile, Supriya G, Dale, William, Somerfield, Mark R, Schonberg, Mara A, Boyd, Cynthia M, Burhenn, Peggy S, Canin, Beverly, Cohen, Harvey Jay, Holmes, Holly M, Hopkins, Judith O, Janelsins, Michelle C, Khorana, Alok A, Klepin, Heidi D, Lichtman, Stuart M, Mustian, Karen M, Tew, William P, Hurria, Arti

“…Purpose To provide guidance regarding the practical assessment and management of vulnerabilities in older patients undergoing chemotherapy. Methods An Expert…”
Get full text

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement by Kim, Edward S, Bruinooge, Suanna S, Roberts, Samantha, Ison, Gwynn, Lin, Nancy U, Gore, Lia, Uldrick, Thomas S, Lichtman, Stuart M, Roach, Nancy, Beaver, Julia A, Sridhara, Rajeshwari, Hesketh, Paul J, Denicoff, Andrea M, Garrett-Mayer, Elizabeth, Rubin, Eric, Multani, Pratik, Prowell, Tatiana M, Schenkel, Caroline, Kozak, Marina, Allen, Jeff, Sigal, Ellen, Schilsky, Richard L

“…Purpose The primary purposes of eligibility criteria are to protect the safety of trial participants and define the trial population. Excessive or overly…”
Get full text

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study by HURRIA, Arti, TOGAWA, Kayo, KLAPPER, Shira, HANSEN, Kurt, RAMANI, Rupal, LACHS, Mark, WONG, F. Lennie, TEW, William P, MOHILE, Supriya G, OWUSU, Cynthia, KLEPIN, Heidi D, GROSS, Cary P, LICHTMAN, Stuart M, GAJRA, Ajeet, BHATIA, Smita, KATHERIA, Vani

“…Older adults are vulnerable to chemotherapy toxicity; however, there are limited data to identify those at risk. The goals of this study are to identify risk…”
Get full text

End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article by WILDIERS, Hans, MAUER, Murielle, COHEN, Harvey Jay, MUSS, Hyman, WEDDING, Ulrich, PALLIS, Athanasios, HURRIA, Arti, MOHILE, Supriya G, LUCIANI, Andrea, CURIGLIANO, Giuseppe, EXTERMANN, Martine, LICHTMAN, Stuart M, BALLMAN, Karla

“…Selecting the most appropriate end points for clinical trials is important to assess the value of new treatment strategies. Well-established end points for…”
Get full text

Long-term Toxicity of Cancer Treatment in Older Patients by Shahrokni, Armin, MD, MPH, Wu, Abraham J., MD, Carter, Jeanne, PhD, Lichtman, Stuart M., MD

“…With earlier cancer diagnosis among older patients with cancer, the possibility of curing cancer increases. However, cancer treatment may have a long-lasting…”
Get full text

Breast and ovarian cancer in the older woman by Tew, William P, Muss, Hyman B, Kimmick, Gretchen G, Von Gruenigen, Vivian E, Lichtman, Stuart M

“…Nearly half of all women diagnosed with breast or ovarian cancer are age 65 years or older with the number of women diagnosed expected to increase as the…”
Get full text

International Society of Geriatric Oncology Chemotherapy Taskforce: Evaluation of Chemotherapy in Older Patients—An Analysis of the Medical Literature by Lichtman, Stuart M, Wildiers, Hans, Chatelut, Etienne, Steer, Christopher, Budman, Daniel, Morrison, Vicki A, Tranchand, Brigitte, Shapira, Iuliana, Aapro, Matti

“…The elderly comprise the majority of patients with cancer and are the recipients of the greatest amount of chemotherapy. Unfortunately, there is a lack of data…”
Get full text

Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology by Goldberg, Richard M, Adams, Richard, Buyse, Marc, Eng, Cathy, Grothey, Axel, André, Thierry, Sobrero, Alberto F, Lichtman, Stuart M, Benson, Al B, Punt, Cornelis J A, Maughan, Tim, Burzykowski, Tomasz, Sommeijer, Dirkje, Saad, Everardo D, Shi, Qian, Coart, Elisabeth, Chibaudel, Benoist, Koopman, Miriam, Schmoll, Hans-Joachim, Yoshino, Takayuki, Taieb, Julien, Tebbutt, Niall C, Zalcberg, John, Tabernero, Josep, Van Cutsem, Eric, Matheson, Alastair, de Gramont, Aimery

“…Abstract Meta-analysis based on individual participant data (IPD) is a powerful methodology for synthesizing evidence by combining information drawn from…”
Get full text

Distress in Older Patients With Cancer by HURRIA, Arti, DANENG LI, GARDES, Jonathan, LIMAYE, Sewanti, LACHS, Mark, KELLY, Eva, HANSEN, Kurt, PATIL, Sujata, GUPTA, Ravi, NELSON, Christian, LICHTMAN, Stuart M, TEW, William P, HAMLIN, Paul, ZUCKERMAN, Enid

“…To determine the predictors of distress in older patients with cancer. Patients age >or= 65 years with a solid tumor or lymphoma completed a questionnaire that…”
Get full text

A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes by Davidoff, Amy J, Zuckerman, Ilene H, Pandya, Naimish, Hendrick, Franklin, Ke, Xuehua, Hurria, Arti, Lichtman, Stuart M, Hussain, Arif, P.Weiner, Jonathan, Edelman, Martin J

“…Abstract Objectives To develop and provide initial validation for a multivariate, claims-based prediction model for disability status (DS), a proxy measure of…”
Get full text

Missed Opportunities in Geriatric Oncology Research by Lichtman, Stuart M

“…Abstract The field of geriatric oncology has made significant progress in recent decades, but there are still missed opportunities in important areas of…”
Get full text

Chemotherapy of ovarian cancer in elderly patients by Troso-Sandoval, Tiffany A., Lichtman, Stuart M.

“…Epithelial ovarian cancer is primarily a disease of older women. Advanced age is risk factor for decreased survival. Optimal surgery and the safe and effective…”
Get full text

Systemic therapy of non-colorectal gastrointestinal malignancies in the elderly by Desai, Avni M, Lichtman, Stuart M

“…In the coming years life expectancy is expected to increase and with this the percentage of the population above age 65 will grow. Patients above 65 make up…”
Get full text

Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology by ROTH, Bruce J, KRILOV, Lada, GILBERT, Mark R, JACOBSON, Joseph O, LARSEN, Eric C, LICHTMAN, Stuart M, PARTRIDGE, Ann H, PATEL, Jyoti D, QUINN, David I, ROBISON, Leslie L, VON ROENN, Jamie H, SAMLOWSKI, Wolfram, ADAMS, Sylvia, SCHWARTZ, Gary K, VOGELZANG, Nicholas J, AGHAJANIAN, Carol A, BACH, Peter, BRAITEH, Fadi, BROSE, Marcia S, ELLIS, Lee M, ERBA, Harry, GEORGE, Daniel J

“…A MESSAGE FROM ASCO'S PRESIDENT I am delighted to present you with “Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer From the American…”
Get full text

Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer by Tanner, Edward J, Black, Destin R, Zivanovic, Oliver, Kehoe, Siobhan M, Dao, Fanny, Konner, Jason A, Barakat, Richard R, Lichtman, Stuart M, Levine, Douglas A

“…Abstract Objective Adjuvant intraperitoneal (IP) platinum-based chemotherapy has been shown to improve outcome for patients with advanced ovarian cancer. We…”
Get full text

The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment by O'Cearbhaill, Roisin, Zhou, Qin, Iasonos, Alexia, Hensley, Martee L, Tew, William P, Aghajanian, Carol, Spriggs, David R, Lichtman, Stuart M, Sabbatini, Paul J

“…Abstract Objective Repeated exposure to carboplatin can lead to hypersensitivity reactions during retreatment with carboplatin. This may prevent its further…”
Get full text

Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situation by Sprangers, Ben, Van der Veen, Annelien, Hamaker, Marije E, Rostoft, Siri, Latcha, Sheron, Lichtman, Stuart M, de Moor, Bart, Wildiers, Hans

“…Cancer and chronic kidney disease prevalence both increase with age. As a consequence, physicians are more frequently encountering older people with cancer who…”
Get full text

Pharmacokinetics of chemotherapy in the older patient by Hurria, Arti, Lichtman, Stuart M

“…The number of individuals aged 65 years and older is growing rapidly, and the majority of cancers are diagnosed in this age group. Age-related changes in…”
Get more information

Phase I and Pharmacokinetic Study of Erlotinib for Solid Tumors in Patients With Hepatic or Renal Dysfunction: CALGB 60101 by MILLER, Antonius A, MURRY, Daryl J, LICHTMAN, Stuart M, RATAIN, Mark J, OWZAR, Kouros, HOLLIS, Donna R, LEWIS, Lionel D, KINDLER, Hedy L, MARSHALL, John L, VILLALONA-CALERO, Miguel A, EDELMAN, Martin J, HOHL, Raymond

“…We investigated dose and pharmacokinetics of erlotinib in patients with hepatic dysfunction or renal dysfunction. Patients were assigned to one of three…”
Get full text

Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement by Hurria, Arti, Levit, Laura A, Dale, William, Mohile, Supriya G, Muss, Hyman B, Fehrenbacher, Louis, Magnuson, Allison, Lichtman, Stuart M, Bruinooge, Suanna S, Soto-Perez-de-Celis, Enrique, Tew, William P, Postow, Michael A, Cohen, Harvey J

“…The American Society of Clinical Oncology (ASCO) convened a subcommittee to develop recommendations on improving the evidence base for treating older adults…”
Get full text